Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Ocular Therapeutix Inc. (OCUL)

8.25   -0.08 (-0.96%) 07-01 16:00
Open: 8.3 Pre. Close: 8.33
High: 8.65 Low: 7.85
Volume: 915,210 Market Cap: 518M
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel platform technology. The company markets ReSure Sealant, a hydrogel ophthalmic wound sealant to seal corneal incisions following cataract surgery. Its lead product candidate is DEXTENZA (dexamethasone ophthalmic insert), which has completed two Phase III clinical trials for the treatment of post-surgical ocular pain and inflammation, and allergic conjunctivitis; and DEXTENZA, which is in Phase III clinical trials for the treatment of dry eye diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 8.66 - 8.706 8.706 - 8.745
Low: 7.75 - 7.798 7.798 - 7.838
Close: 8.168 - 8.253 8.253 - 8.325

Technical analysis

as of: 2020-07-01 4:35:38 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 10.79     One year: 12.61
Support: Support1: 7.61    Support2: 6.61
Resistance: Resistance1: 9.24    Resistance2: 10.79
Pivot: 8.43
Moving Average: MA(5): 8.36     MA(20): 8.17
MA(100): 6.14     MA(250): 4.89
MACD: MACD(12,26): 0.42     Signal(9): 0.51
Stochastic oscillator: %K(14,3): 57.06     %D(3): 58.80
RSI: RSI(14): 56.02
52-week: High: 9.24  Low: 2.46  Change(%): 60.2
Average Vol(K): 3-Month: 96922  10-Days: 104073

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
OCUL has closed above bottom band by 41.6%. Bollinger Bands are 6.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 01 Jul 2020
Riding the Trend or Protecting Profits: Ocular Therapeutix, Inc. (OCUL) - The News Heater

Fri, 26 Jun 2020
Breaking News: Ocular Therapeutix, Inc. (OCUL) On A Technical Move, Learn Why - Invest Million

Fri, 19 Jun 2020
Is Now the Time to Invest in Ocular Therapeutix Inc. (NASDAQ:OCUL)? - The Oracle Dispatch

Thu, 18 Jun 2020
Is a Correction Looming Ahead? Ocular Therapeutix, Inc. (OCUL) - The News Heater

Thu, 18 Jun 2020
Is Ocular Therapeutix Inc (OCUL) a Winner in the Biotechnology Industry? - InvestorsObserver

Mon, 15 Jun 2020
Ocular Therapeutix™ to Hold Virtual 2020 Annual Meeting Of Stockholders - Business Wire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 63
Shares Float (M) 47
% Held by Insiders 9.89
% Held by Institutions 50.83
Shares Short (K) 5,620
Shares Short P. Month (K) 5,490

Stock Financials

EPS -1.900
EPS Est This Year -2.290
EPS Est Next Year -2.110
Book Value (p.s.) -0.200
Profit Margin
Operating Margin -1304.51
Return on Assets (ttm) -59.3
Return on Equity (ttm) -1211.0
Qtrly Rev. Growth 430.3
Gross Profit (p.s.) -0.624
Sales Per Share 0.101
EBITDA (p.s.) -1.276
Qtrly Earnings Growth
Operating Cash Flow (M) -77
Levered Free Cash Flow (M) -51

Stock Valuations

PE Ratio -4.34
PEG Ratio
Price to Book value -41.25
Price to Sales 81.68
Price to Cash Flow -6.72

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.